 | • レポートコード：MRC2012A6601 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、オピオイド誘発性便秘（OIC）治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。オピオイド誘発性便秘（OIC）治療薬の種類別市場規模（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Ironwood Pharmaceuticals Inc、Purdue Pharma、Progenics Pharmaceuticals Inc、Daiichi Sankyo Co Ltd、Nektar Therapeutics、Pfizer、Mundipharma International Limited、Allergan Plc、Shionogi & Co., Ltd、S.L.A. Pharma AG、Cosmo Pharmaceuticals SA、Sucampo Pharmaceuticals、Ono Pharmaceutical Co., Ltd、Daewoong Pharmaceutical、Bausch Health、Takeda Pharmaceutical Company Limited、C.B. Fleet Company、Theravance Biopharma Inc、 ・地域別グローバル市場分析 2015年-2020年 ・オピオイド誘発性便秘（OIC）治療薬の北米市場（アメリカ、カナダ、メキシコ） ・オピオイド誘発性便秘（OIC）治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・オピオイド誘発性便秘（OIC）治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・オピオイド誘発性便秘（OIC）治療薬の南米市場（ブラジル、アルゼンチン） ・オピオイド誘発性便秘（OIC）治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Opioid Induced Constipation (OIC) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Opioid Induced Constipation (OIC) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Opioid Induced Constipation (OIC) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Opioid Induced Constipation (OIC) Drugs market has been segmented into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
By Application, Opioid Induced Constipation (OIC) Drugs has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioid Induced Constipation (OIC) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioid Induced Constipation (OIC) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioid Induced Constipation (OIC) Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Opioid Induced Constipation (OIC) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Opioid Induced Constipation (OIC) Drugs Market Share Analysis
Opioid Induced Constipation (OIC) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Opioid Induced Constipation (OIC) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioid Induced Constipation (OIC) Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Opioid Induced Constipation (OIC) Drugs are:
Ironwood Pharmaceuticals Inc
Purdue Pharma
Progenics Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Nektar Therapeutics
Pfizer
Mundipharma International Limited
Allergan Plc
Shionogi & Co., Ltd
S.L.A. Pharma AG
Cosmo Pharmaceuticals SA
Sucampo Pharmaceuticals
Ono Pharmaceutical Co., Ltd
Daewoong Pharmaceutical
Bausch Health
Takeda Pharmaceutical Company Limited
C.B. Fleet Company
Theravance Biopharma Inc
Among other players domestic and global, Opioid Induced Constipation (OIC) Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioid Induced Constipation (OIC) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid Induced Constipation (OIC) Drugs, with price, sales, revenue and global market share of Opioid Induced Constipation (OIC) Drugs in 2018 and 2019.
Chapter 3, the Opioid Induced Constipation (OIC) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Induced Constipation (OIC) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Opioid Induced Constipation (OIC) Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Opioid Induced Constipation (OIC) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Opioid Induced Constipation (OIC) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioid Induced Constipation (OIC) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioid Induced Constipation (OIC) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Overview of Global Opioid Induced Constipation (OIC) Drugs Market
1.4.1 Global Opioid Induced Constipation (OIC) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Ironwood Pharmaceuticals Inc
2.1.1 Ironwood Pharmaceuticals Inc Details
2.1.2 Ironwood Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ironwood Pharmaceuticals Inc SWOT Analysis
2.1.4 Ironwood Pharmaceuticals Inc Product and Services
2.1.5 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Purdue Pharma
2.2.1 Purdue Pharma Details
2.2.2 Purdue Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Purdue Pharma SWOT Analysis
2.2.4 Purdue Pharma Product and Services
2.2.5 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Progenics Pharmaceuticals Inc
2.3.1 Progenics Pharmaceuticals Inc Details
2.3.2 Progenics Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Progenics Pharmaceuticals Inc SWOT Analysis
2.3.4 Progenics Pharmaceuticals Inc Product and Services
2.3.5 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Daiichi Sankyo Co Ltd
2.4.1 Daiichi Sankyo Co Ltd Details
2.4.2 Daiichi Sankyo Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Daiichi Sankyo Co Ltd SWOT Analysis
2.4.4 Daiichi Sankyo Co Ltd Product and Services
2.4.5 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Nektar Therapeutics
2.5.1 Nektar Therapeutics Details
2.5.2 Nektar Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Nektar Therapeutics SWOT Analysis
2.5.4 Nektar Therapeutics Product and Services
2.5.5 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mundipharma International Limited
2.7.1 Mundipharma International Limited Details
2.7.2 Mundipharma International Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mundipharma International Limited SWOT Analysis
2.7.4 Mundipharma International Limited Product and Services
2.7.5 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Allergan Plc
2.8.1 Allergan Plc Details
2.8.2 Allergan Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Allergan Plc SWOT Analysis
2.8.4 Allergan Plc Product and Services
2.8.5 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Shionogi & Co., Ltd
2.9.1 Shionogi & Co., Ltd Details
2.9.2 Shionogi & Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Shionogi & Co., Ltd SWOT Analysis
2.9.4 Shionogi & Co., Ltd Product and Services
2.9.5 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 S.L.A. Pharma AG
2.10.1 S.L.A. Pharma AG Details
2.10.2 S.L.A. Pharma AG Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 S.L.A. Pharma AG SWOT Analysis
2.10.4 S.L.A. Pharma AG Product and Services
2.10.5 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cosmo Pharmaceuticals SA
2.11.1 Cosmo Pharmaceuticals SA Details
2.11.2 Cosmo Pharmaceuticals SA Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Cosmo Pharmaceuticals SA SWOT Analysis
2.11.4 Cosmo Pharmaceuticals SA Product and Services
2.11.5 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sucampo Pharmaceuticals
2.12.1 Sucampo Pharmaceuticals Details
2.12.2 Sucampo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sucampo Pharmaceuticals SWOT Analysis
2.12.4 Sucampo Pharmaceuticals Product and Services
2.12.5 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ono Pharmaceutical Co., Ltd
2.13.1 Ono Pharmaceutical Co., Ltd Details
2.13.2 Ono Pharmaceutical Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ono Pharmaceutical Co., Ltd SWOT Analysis
2.13.4 Ono Pharmaceutical Co., Ltd Product and Services
2.13.5 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Daewoong Pharmaceutical
2.14.1 Daewoong Pharmaceutical Details
2.14.2 Daewoong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Daewoong Pharmaceutical SWOT Analysis
2.14.4 Daewoong Pharmaceutical Product and Services
2.14.5 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Bausch Health
2.15.1 Bausch Health Details
2.15.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Bausch Health SWOT Analysis
2.15.4 Bausch Health Product and Services
2.15.5 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Takeda Pharmaceutical Company Limited
2.16.1 Takeda Pharmaceutical Company Limited Details
2.16.2 Takeda Pharmaceutical Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Takeda Pharmaceutical Company Limited SWOT Analysis
2.16.4 Takeda Pharmaceutical Company Limited Product and Services
2.16.5 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 C.B. Fleet Company
2.17.1 C.B. Fleet Company Details
2.17.2 C.B. Fleet Company Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 C.B. Fleet Company SWOT Analysis
2.17.4 C.B. Fleet Company Product and Services
2.17.5 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Theravance Biopharma Inc
2.18.1 Theravance Biopharma Inc Details
2.18.2 Theravance Biopharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Theravance Biopharma Inc SWOT Analysis
2.18.4 Theravance Biopharma Inc Product and Services
2.18.5 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Opioid Induced Constipation (OIC) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Opioid Induced Constipation (OIC) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
4.5 South America Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
6.3 UK Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
6.4 France Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
7.5 India Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Opioid Induced Constipation (OIC) Drugs Price by Type (2015-2020)
11 Global Opioid Induced Constipation (OIC) Drugs Market Segment by Application
11.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)
11.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Opioid Induced Constipation (OIC) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Opioid Induced Constipation (OIC) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025)
12.2.2 Europe Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025)
12.2.4 South America Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025)
12.3 Opioid Induced Constipation (OIC) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Opioid Induced Constipation (OIC) Drugs Market Share Forecast by Type (2021-2025)
12.4 Opioid Induced Constipation (OIC) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Opioid Induced Constipation (OIC) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Opioid Induced Constipation (OIC) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Opioid Induced Constipation (OIC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Opioid Induced Constipation (OIC) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Ironwood Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 8. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Major Business
Table 9. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Ironwood Pharmaceuticals Inc SWOT Analysis
Table 11. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 12. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Major Business
Table 15. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Purdue Pharma SWOT Analysis
Table 17. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product and Services
Table 18. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Progenics Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 20. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Major Business
Table 21. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Progenics Pharmaceuticals Inc SWOT Analysis
Table 23. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 24. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 26. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Major Business
Table 27. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Daiichi Sankyo Co Ltd SWOT Analysis
Table 29. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
Table 30. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Major Business
Table 33. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Nektar Therapeutics SWOT Analysis
Table 35. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product and Services
Table 36. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Opioid Induced Constipation (OIC) Drugs Major Business
Table 39. Pfizer Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Opioid Induced Constipation (OIC) Drugs Product and Services
Table 42. Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mundipharma International Limited Basic Information, Manufacturing Base and Competitors
Table 44. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Major Business
Table 45. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Mundipharma International Limited SWOT Analysis
Table 47. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product and Services
Table 48. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Allergan Plc Basic Information, Manufacturing Base and Competitors
Table 50. Allergan Plc Opioid Induced Constipation (OIC) Drugs Major Business
Table 51. Allergan Plc Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Allergan Plc SWOT Analysis
Table 53. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 54. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Shionogi & Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Major Business
Table 57. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Shionogi & Co., Ltd SWOT Analysis
Table 59. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
Table 60. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. S.L.A. Pharma AG Basic Information, Manufacturing Base and Competitors
Table 62. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Major Business
Table 63. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 64. S.L.A. Pharma AG SWOT Analysis
Table 65. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product and Services
Table 66. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Cosmo Pharmaceuticals SA Basic Information, Manufacturing Base and Competitors
Table 68. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Major Business
Table 69. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Cosmo Pharmaceuticals SA SWOT Analysis
Table 71. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product and Services
Table 72. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Major Business
Table 75. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Sucampo Pharmaceuticals SWOT Analysis
Table 77. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
Table 78. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Major Business
Table 81. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Ono Pharmaceutical Co., Ltd SWOT Analysis
Table 83. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
Table 84. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Major Business
Table 87. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Daewoong Pharmaceutical SWOT Analysis
Table 89. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product and Services
Table 90. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 92. Bausch Health Opioid Induced Constipation (OIC) Drugs Major Business
Table 93. Bausch Health Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Bausch Health SWOT Analysis
Table 95. Bausch Health Opioid Induced Constipation (OIC) Drugs Product and Services
Table 96. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 98. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Major Business
Table 99. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 100. Takeda Pharmaceutical Company Limited SWOT Analysis
Table 101. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product and Services
Table 102. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. C.B. Fleet Company Basic Information, Manufacturing Base and Competitors
Table 104. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Major Business
Table 105. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 106. C.B. Fleet Company SWOT Analysis
Table 107. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product and Services
Table 108. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Type and Application
Table 110. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Major Business
Table 111. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Total Revenue (USD Million) (2017-2018)
Table 112. Theravance Biopharma Inc SWOT Analysis
Table 113. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 114. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Opioid Induced Constipation (OIC) Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 116. Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Opioid Induced Constipation (OIC) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 118. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Regions (2015-2020)
Table 119. Global Opioid Induced Constipation (OIC) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Opioid Induced Constipation (OIC) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 121. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries (2015-2020)
Table 122. North America Opioid Induced Constipation (OIC) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2015-2020)
Table 124. Europe Opioid Induced Constipation (OIC) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 125. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries (2015-2020)
Table 126. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 128. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Opioid Induced Constipation (OIC) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 131. South America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries (2015-2020)
Table 132. South America Opioid Induced Constipation (OIC) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 135. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2015-2020)
Table 138. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2015-2020) (K Pcs)
Table 139. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2015-2020)
Table 140. Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2015-2020) (USD Million)
Table 141. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2015-2020)
Table 142. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2015-2020) (K Pcs)
Table 143. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Application (2015-2020)
Table 144. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 145. Global Opioid Induced Constipation (OIC) Drugs Market Share Forecast by Regions (2021-2025)
Table 146. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 147. Global Opioid Induced Constipation (OIC) Drugs Market Share Forecast by Type (2021-2025)
Table 148. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2021-2025)
Table 149. Global Opioid Induced Constipation (OIC) Drugs Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Opioid Induced Constipation (OIC) Drugs Picture
Figure 2. Global Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Type in 2019
Figure 3. Lubiprostone Picture
Figure 4. Methyl Naltrexone Bromide Picture
Figure 5. Naldemedine Picture
Figure 6. Alvimopan Picture
Figure 7. Other Picture
Figure 8. Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2018
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Opioid Induced Constipation (OIC) Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Opioid Induced Constipation (OIC) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Opioid Induced Constipation (OIC) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries in 2018
Figure 49. North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Regions 2019
Figure 65. China Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries in 2019
Figure 72. South America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Opioid Induced Constipation (OIC) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
オピオイド誘発性便秘（OIC）治療の世界市場（～2026年） Market Analysis and Insights: Global Opioid-Induced Constipation (OIC) Treatment Market The global Opioid-Induced Constipation (OIC) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Opioid-Induced Constipation…- オピオイド誘発性便秘治療の世界市場（～2026年） There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …
- オピオイド誘発性便秘（OIC）治療薬の世界市場（～2026年） Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas. Market Analysis and Insights: Global Opioid Induced Constipation (OIC) Drug Market The global Opioid…
- オピオイド誘発性便秘の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Opioid-Induced Constipation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 便秘の世界市場（～2026年） Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing …